1. A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus. (June 2013) Authors: Kan, Hong; Guerin, Annie; Kaminsky, Michael S.; Yu, Andrew P.; Wu, Eric Q.; Denio, Alfred; Priti, Jhingran; Narayanan, Siva; Molta, Charles Journal: Journal of medical economics Issue: Volume 16:Number 6(2013) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set. Issue 3 (11th October 2011) Authors: FitzGerald, Oliver; Helliwell, Philip; Mease, Philip; Mumtaz, Aizad; Coates, Laura; Pedersen, Ronald; Nab, Henk; Molta, Charles Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 3(2012) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term, continuous dosing of etanercept in patients with plaque psoriasis. (August 2011) Authors: Papp, Kim A; Krueger, Gerald G; Jemec, Gregor BE; van de Kerkhof, Peter; Robertson, Deborah; Estojak, Joanne; Pedersen, Ronald; Foehl, Joanne; Wajdula, Joseph; Boggs, Robert; Molta, Charles Journal: Expert review of dermatology Issue: Volume 6:Number 4(2011) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗